Agrawal Ruchita, Verma Shikha, Vatsalya Vatsalya, Halappanavar Monica, Oraka Kosisochukwu
Psychiatry, Seven Counties Services, Louisville, USA.
Psychiatry and Behavioral Health, Rosalind Franklin University, North Chicago, USA.
Cureus. 2021 Jan 18;13(1):e12763. doi: 10.7759/cureus.12763.
Post-stroke psychosis is prevalent and disabling with increased mortality risk. Treatment for post-stroke psychosis is limited in this staggering medical concern. The most commonly used medications are antipsychotics, however, the risk for stroke increases further with the use of antipsychotics. Furthermore, interventional clinical studies have not been carried out to test the efficacy and safety of antipsychotics in the management of post-stroke psychosis. We present a case of post-stroke psychosis to highlight the risks faced by these patients in terms of daily function and safety concerns and the challenges encountered in treatment due to poor response to the conventional antipsychotics; and so calling attention to early diagnosis and improved treatment options. More clinical investigations are needed to address the pathology associated with the clinical presentation and exploring the pharmacotherapies to improve efficacy and safety of treatment for post-stroke psychosis.
中风后精神病很常见且会导致残疾，同时死亡风险增加。在这个令人震惊的医学问题中，中风后精神病的治疗方法有限。最常用的药物是抗精神病药，然而，使用抗精神病药会进一步增加中风风险。此外，尚未开展干预性临床研究来测试抗精神病药在治疗中风后精神病方面的疗效和安全性。我们报告一例中风后精神病病例，以强调这些患者在日常功能和安全方面面临的风险，以及由于对传统抗精神病药反应不佳在治疗中遇到的挑战；从而呼吁关注早期诊断和改进治疗方案。需要更多的临床研究来解决与临床表现相关的病理问题，并探索提高中风后精神病治疗疗效和安全性的药物疗法。
